JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, E. G.
Right arrow Articles by Banna, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, E. G.
Right arrow Articles by Banna, N. R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 158, Issue 3, 405-415, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECTS OF MONOAMINE OXIDASE INHIBITORS ON SPINAL SYNAPTIC ACTIVITY

Edmund G. Anderson 1, Robert G. Baker 1, and Nabil R. Banna 1

1 Department of Pharmacology, University of Illinois, College of Medicine, Chicago, Illinois

The effect of several monoamine oxidase (MAO) inhibitors was investigated on spinal neuronal potentials recorded from an L7 ventral root and evoked by stimulation of an L7 dorsal root. Within 3 to 4 hr after the injection of the MAO inhibitors, pargyline, nialamide, tranylcypromine and agr-ethyltryptamine, the monosynaptic spike height was selectively increased whereas the polysynaptic potentials remained unchanged. The increase in the monosynaptic spike height was statistically significant with each compound. The following results indicated that this action was associated with MAO inhibition and the accumulation of 5-hydroxytryptamine (5-HT). Four hours after the injection of pargyline, cord levels of 5-HT and norepinephrine (NE) were increased by 70 and 17%, respectively. Four hours after pretreatment with a MAO inhibitor the actions of 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (dopa) on spinal reflexes were strongly potentiated. Chronic reserpine treatment did not prevent the effects of pargyline or 5-HTP but strongly depressed the response to dopa. The increase of the monosynaptic spike height induced by the MAO inhibitors was immediately antagonized by the 5-HT antagonist methysergide but was not prevented by the NE antagonist phenoxybenzamine.

Submitted on April 4, 1967
Accepted on July 31, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.